---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-115932"
form_type: "8-K"
ticker: "SENS"
cik: "0001616543"
company_name: "Senseonics Holdings, Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:42:26.056836+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Senseonics Q3 revenue $4.6M (+31% YoY); net loss $60.4M on non-cash fair value adjustments

## Summary
- Revenue $4.6M vs $3.5M a year ago; U.S. revenue $1.9M (up from $0.6M), OUS $2.7M.
- Net loss of $60.4M ($0.13/share) compared to net income of $42.9M ($0.10/share) in Q3 2021 due to non-cash items.
- Gross profit improved to $0.8M from negative $1.2M in the prior-year period.
- FY 2022 revenue guidance narrowed to $15-17M from prior $14-18M range.
- Completed enrollment of pivotal 365-day sensor trial; Eversense E3 launched globally with Ascensia.

## SEC filing metadata
- accession: 0001104659-22-115932
- form_type: 8-K
- ticker: SENS
- cik: 0001616543
- company_name: Senseonics Holdings, Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1616543/000110465922115932/0001104659-22-115932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1616543/000110465922115932/tm2229974d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-115932
- JSON: https://secwatch.observer/filing/0001104659-22-115932.json
- Plain text: https://secwatch.observer/filing/0001104659-22-115932.txt

## Key facts
- Earnings Releases
  Senseonics Holdings, Inc. reported the quarter ended September 30, 2022 results: revenue $4.6 million, net income $60.4 million, or ($0.13) per share, EPS ($0.13) per share. Guidance lowered.
  - Period: the quarter ended September 30, 2022
  - Revenue: $4.6 million
  - Net income: $60.4 million, or ($0.13) per share
  - EPS: ($0.13) per share
  - Guidance: lowered
  - Result: reported results
  source text: sensor. ● Received positive coverage decisions from Blue Cross Blue Shield of Florida and others, adding 5 million covered lives for Eversense E3 CGM. ● Generated revenue of $4.6 million in the third quarter of 2022. “Having launched the partnership with the Nurse Practitioner Group to expand access with in-home and in-office insertion options, we continue to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1616543/000110465922115932/0001104659-22-115932-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.